Blueprint Medicines Corpo... (BPMC)
NASDAQ: BPMC
· Real-Time Price · USD
129.46
0.18 (0.14%)
At close: Jul 17, 2025, 3:59 PM
Blueprint Medicines Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 122.25M | 102.01M | 89.36M | 54.77M | 113.33M | 71.29M | 55.97M | 75.53M | 169.72M | 119.71M | 291.43M | 173.4M | 37.2M | 209.95M | 553.59M | 534.32M | 697.97M |
Short-Term Investments | 453.99M | 513.47M | 644.82M | 708.83M | 534.58M | 639.36M | 657.01M | 647.11M | 652.44M | 825.28M | 845.53M | 679.71M | 549.63M | 267.17M | 148.28M | 94.03M | 154M |
Long-Term Investments | n/a | 277.15M | n/a | 143.28M | 126.13M | 94.56M | 142.03M | 141.72M | 166.94M | 161.27M | 83.46M | 94.05M | 306.52M | 557.53M | 591.92M | 751.7M | 578.17M |
Other Long-Term Assets | 395.88M | 59.21M | 240.53M | 47.69M | 22.58M | 30.65M | 39.26M | 38.9M | 39.68M | 26.78M | 29.89M | 27.2M | 30.31M | 19.81M | 19.36M | 16.73M | 10.53M |
Receivables | 79.8M | 77.61M | 65.81M | 85.06M | 60.05M | 43.18M | 41.25M | 38.27M | 31.3M | 36.94M | 21.91M | 29.41M | 32.6M | 37.03M | 29.72M | 39.24M | 43.86M |
Inventory | 12.95M | 13.61M | 12.53M | 14.79M | 30.94M | 21.22M | 16.46M | 17.02M | 17.52M | 29.7M | 35.25M | 35.45M | 30.14M | 21.82M | 16.57M | 15.21M | 16.03M |
Other Current Assets | 33.08M | 35.97M | 42.33M | 40.09M | 37.71M | 33.35M | 37.48M | 33.42M | 29.36M | 35.02M | 33.53M | 34.2M | 37.67M | n/a | 23.68M | 21.27M | n/a |
Total Current Assets | 702.07M | 742.68M | 854.85M | 903.54M | 776.6M | 808.39M | 808.17M | 811.34M | 900.34M | 1.05B | 1.23B | 952.18M | 687.24M | 554.02M | 771.85M | 704.07M | 937.71M |
Property-Plant & Equipment | 97.66M | 100.77M | 104.27M | 109.05M | 113.17M | 115.65M | 115.84M | 114.49M | 113.41M | 115.2M | 117.37M | 119.02M | 119.23M | 120.86M | 94.19M | 96.29M | 98.98M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 493.54M | 437.13M | 344.8M | 300.02M | 261.87M | 240.86M | 297.13M | 295.11M | 320.03M | 303.25M | 230.73M | 240.27M | 456.06M | 698.2M | 705.47M | 864.73M | 687.68M |
Total Assets | 1.2B | 1.18B | 1.2B | 1.2B | 1.04B | 1.05B | 1.11B | 1.11B | 1.22B | 1.35B | 1.46B | 1.19B | 1.14B | 1.25B | 1.48B | 1.57B | 1.63B |
Account Payables | 800K | 6.79M | 4.72M | 4.86M | 4.93M | 4.71M | 6.96M | 6.98M | 10.56M | 2.73M | 4.23M | 15.05M | 17.96M | 8.33M | 9.55M | 1.85M | 2.89M |
Deferred Revenue | 2.28M | 63.66M | 64.02M | 3.75M | 7.25M | 812K | 448.16M | 445.67M | 443.33M | 448.62M | 25.11M | 14.99M | 9.6M | 36.58M | 6.79M | 7.91M | 14.88M |
Short-Term Debt | 57.53M | 43.92M | 45.03M | 114.66M | 30.18M | 69.48M | 30.22M | 17.86M | 17.38M | 16.85M | 15.29M | n/a | 8.76M | n/a | 8.81M | 8.46M | 8.19M |
Other Current Liabilities | 189.97M | 79.54M | 90.61M | 77.67M | 72.74M | 84.56M | 54.25M | 45.29M | 37.15M | 31M | 31.49M | 21.14M | 78.32M | 15.44M | 63.4M | 82.04M | 66.96M |
Total Current Liabilities | 250.58M | 260.8M | 257.66M | 243.8M | 206.6M | 214.92M | 197.38M | 169.03M | 172.68M | 183.23M | 175.51M | 158.76M | 137.03M | 149.76M | 119.69M | 125.4M | 112.44M |
Long-Term Debt | 65.22M | 343.05M | 341.54M | 550.45M | 432.3M | 610.96M | 208.16M | 122.15M | 122.13M | 122.23M | 123.06M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 537.67M | 6.79M | 207.47M | 5.78M | 10.4M | 6.21M | 408.11M | 412.09M | 416.32M | 436.97M | 424.02M | 9.37M | 10.13M | 3.34M | 6.88M | 6.96M | 7.36M |
Total Long-Term Liabilities | 602.89M | 620.35M | 628.84M | 639.52M | 521.18M | 703.72M | 705.3M | 626.29M | 633.39M | 651.99M | 642.58M | 285.94M | 124.62M | 131.72M | 110.54M | 114.59M | 112.93M |
Total Liabilities | 853.47M | 881.15M | 886.5M | 883.32M | 727.79M | 918.64M | 902.69M | 795.32M | 806.07M | 835.23M | 818.09M | 444.7M | 261.64M | 281.49M | 230.24M | 239.99M | 225.37M |
Total Debt | 122.75M | 469.11M | 471.5M | 740.35M | 597.93M | 774.12M | 125.87M | 116.2M | 118.21M | 242.45M | 243.96M | 107.59M | 109.52M | 111.41M | 83.86M | 85.74M | 87.67M |
Common Stock | 65K | 64K | 63K | 63K | 63K | 61K | 61K | 61K | 60K | 60K | 60K | 60K | 60K | 59K | 59K | 59K | 58K |
Retained Earnings | -2.41B | -2.41B | -2.36B | -2.3B | -2.25B | -2.34B | -2.23B | -2.1B | -1.96B | -1.83B | -1.67B | -1.54B | -1.38B | -1.28B | -956.75M | -839.51M | -731.07M |
Comprehensive Income | -3.24M | -3.55M | -1.07M | -3.89M | -3.85M | -3.5M | -2.68M | -4.22M | -4.6M | -10.44M | -14.83M | -14.25M | -12.11M | -4.13M | -5.67M | -5.83M | -5.1M |
Shareholders Equity | 342.13M | 298.67M | 313.15M | 320.24M | 310.69M | 130.61M | 202.61M | 311.13M | 414.3M | 514.68M | 640.31M | 747.75M | 881.67M | 970.74M | 1.25B | 1.33B | 1.4B |
Total Investments | 453.99M | 790.62M | 644.82M | 852.11M | 660.7M | 733.91M | 657.01M | 647.11M | 652.44M | 958.76M | 929M | 773.76M | 856.15M | 824.7M | 740.21M | 845.73M | 732.16M |